Anne Li 2/9/18
An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results. The drug, called apalutamide, reduced the…
Anne Li 2/9/18
Treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy. The…
Anne Li 2/9/18
New research from The Scripps Research Institute (TSRI) may give scientists a chance to target tumors before they…
Anne Li 2/9/18
Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue.…